European Chemical Distributor Roundtable: Weak Demand and Overcapacity Concerns

Overview

This report summarizes key points from the virtual CEO roundtable hosted by Goldman Sachs, ICIS, and the European Chemical Distributors Association (Fecc). The overall tone was pessimistic, pointing out that the European chemical industry will face severe challenges in the second half of the year, featuring not only seasonal demand weakness but also substantial 'value destruction.' Main concerns include exposure of potential overcapacity after the Middle East conflict ends, squeezing of European competitiveness due to surging Chinese chemical exports, and accelerated reformulation by downstream customers due to high costs. Despite the difficult environment, the report believes leading companies with global multi-source supply networks and strong innovation capabilities (such as BASF, Givaudan, Novolesis) are more resilient and maintains its Buy ratings on them.

Core views

Dismal Industry Outlook and Overcapacity Concerns: Executives agreed that even if the Middle East conflict ends, market normalization will be slower than expected, taking 6-8 weeks just to clear backlog vessels. Q3 is expected to be chaotic, with buyers hesitant due to uncertain fair pricing. More critically, conflict resolution could lead to the release of suppressed supply (especially raw materials stuck in the Middle East), exposing underlying overcapacity issues. Surging Chinese Exports Impact Europe: Equilex Chairman noted China leveraged the crisis to significantly boost its position in intermediates and solvents. Due to weak domestic demand and constrained raw material supplies in other Asian countries, China's excess capacity was forced outward. ICIS data shows Chinese chemical exports to other parts of Asia grew by 70% in March and April, severely disrupting markets and weakening European competitiveness. Structural Changes: Reformulation and Sourcing Shift: High raw material prices forced operators and consumers into reformulation. While some viewed as temporary measures, IMCD CEO confirmed this trend has risen significantly and some may become permanent changes, presenting both challenges and opportunities for specialty chemical distributors. Meanwhile, local European procurement share dropped from about 80% three years ago to current 60%. Although customers still value local European production for supply security, many products are unavailable in Europe, prompting customers to call for resuming production of certain chemicals. Preference for Innovation and Global Integration Partners: In specialty chemicals and ingredients, customers increasingly prefer suppliers offering long-term innovation support. IMCD emphasized that beyond price and supply, innovation capability is key for long-term cooperation. Therefore, the report favors companies with high customer-customized formula sales ratios (e.g., Givaudan 96%) and high R&D spending (e.g., Novolesis 11%). Additionally, companies like BASF with global multi-source supply networks (factories in US, China) can avoid shortages through flexible network allocation, demonstrating strategic importance.

Analysis framework

Goldman Sachs participated in industry executive roundtables to directly obtain frontline distributor and manufacturer CEOs' latest assessments of market status, supply chain dynamics, and competitive landscape. The analysis logic unfolds from three dimensions: macro geopolitics (Middle East conflict, Suez Canal), regional competition (Chinese export data), and micro operations (reformulation, inventory management, sourcing changes), deriving conclusions on overall industry prosperity. Based on this, combined with specific business structures of each company (e.g., global layout, R&D intensity, customization ratio), it evaluates their ability to withstand industry downturn risks, thereby reaching individual stock rating conclusions.

Methodology notes

• Industry/Industrial Analysis FrameworkSupply-demand framework

  Supply-Demand Balance and Capacity Cycle

  The report analyzes the temporary disruption of supply chains by geopolitical conflicts and the subsequent supply release to determine if the industry faces potential overcapacity. This is a typical application of a supply-demand framework, focusing on the suppressing effect of supply-side rebound on prices and profits after external shocks subside.

• Industry/Industrial Analysis FrameworkUpstream/Midstream/Downstream Transmission in Industry Chain

  Cost Transmission and Formula Reformulation

  The report observes that when upstream raw material high costs transmit to downstream, it triggers customer 'formula reformulation' behavior. This reflects the response mechanism of the mid-to-downstream industry chain to cost pressure. Such structural changes may permanently alter demand structures, which is a key perspective for analyzing demand resilience in the chemical industry.

• Valuation MethodEV/EBITDA valuation

  EV/DACF Valuation Multiple

  When valuing BASF, the report used Enterprise Value/Debt-Adjusted Cash Flow (EV/DACF) multiples and adjusted the multiple based on differences in projected Capital Return on Invested Capital (CROCI) relative to historical levels. This is a relative valuation method based on cash flow and capital efficiency.

• Valuation MethodDCF Cash Flow Discounting

  Two-Stage DCF Model

  Valuation for Givaudan and Novolesis uses a two-stage Discounted Cash Flow (DCF) model, setting specific Weighted Average Cost of Capital (WACC) and terminal growth rates. This is a common absolute valuation method for evaluating mature enterprises with stable cash flows and long-term growth potential.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• BASF (BASF)

  Benefit/Steady

  Strengths

  Global integrated supplier with multi-source supply network (US, China), helping distributors avoid shortages; strategic importance highlighted.

  Weaknesses

  Highly affected by European industrial stagnation and energy costs; delays in Zhanjiang base launch or low margins may affect earnings.

  Comparison

  Compared to purely European local producers, its global layout provides stronger supply chain resilience.

  Risks

  Persistent European demand weakness; intensified Chinese competition; M&A value destruction; reopening of Suez Canal leads to increased Asian imports.

• Givaudan (Givaudan)

  Benefit/Innovation Leader

  Strengths

  Extremely high customer custom formula sales ratio (96%), high R&D investment, meeting downstream demand for long-term innovation partners.

  Weaknesses

  If Middle East conflict escalates further disrupting supply chains, may impact sales and costs; excessive cost control may limit organic growth.

  Comparison

  In specialty flavors and fragrances, its innovation capability and customer stickiness are superior to industry averages.

  Risks

  Emerging market consumers prefer home cooking over dining out; fine fragrance growth slows; loss of market share.

• Novolesis (Novolesis)

  Benefit/Innovation Leader

  Strengths

  High R&D spending (11%), leading in enzyme preparations and bio-solutions, aligning with sustainability and innovation trends.

  Weaknesses

  Integration risks post-merger; dependence on Chinese outdoor consumption market (Food & Beverage segment).

  Comparison

  Compared to traditional chemical companies, its advantages in biotechnology and sustainability align better with long-term trends.

  Risks

  Delayed delivery of integration synergies; oil price drop reduces economic viability of enzyme substitutes for petrochemicals; weak animal nutrition demand.

Key data

• Growth Rate of Chinese Chemical Exports to Asia70%Significant YoY/QoQ growth in Mar/Apr, reflecting overseas overflow of China's excess capacity
• Change in Local European Procurement Ratio80% -> 60%Dropped from 80% to 60% over the past three years, showing a trend of de-Europeization in supply chains
• Time to Clear Backlog Vessels6-8 weeksEstimated logistics recovery time needed after Middle East conflict ends
• Givaudan Custom Formula Sales Ratio96%Far above the ingredients industry average of 52%, reflecting its innovation and customer stickiness
• Novolesis R&D Spending Ratio11%Higher than the ingredients industry average of 6%, supporting its long-term innovation advantage
• BASF Target Price€63Based on 9.91x EV/DACF valuation
• Givaudan Target PriceCHF 3,500Based on two-stage DCF, WACC 6.5%, terminal growth rate 2.7%
• Novolesis Target PriceDkr475Based on two-stage DCF, WACC 7.1%, terminal growth rate 2.7%

Impact & implications

The report believes the European chemical industry is undergoing profound structural adjustment. Short-term: weak demand and overcapacity will suppress corporate earnings; Long-term: improved Chinese competitiveness and supply chain restructuring will reshape the industry landscape. For investors, avoid companies relying on single European sources lacking innovation capabilities; instead allocate to leaders with global multi-source supply networks, high R&D investment, and high customization ratios. These companies can better cope with supply chain disruptions and maintain pricing power and market share through innovation.

Risks

• Escalation of Middle East conflict further disrupts supply chains and raw material supply.
• European recession or prolonged German industrial stagnation leads to weaker-than-expected demand in key end markets (autos, construction, consumer goods).
• Chinese chemical manufacturers intensify competition on cost and capacity.
• Full reopening of Suez Canal lowers logistics costs and increases Asian chemical imports to Europe.
• Permanent shutdown of European chemical plants due to carbon limits or refinery closures causes supply disruptions and margin erosion.
• Companies like BASF engage in value-destructive M&A.
• Problems in integration post-Novolesis merger, delayed synergy delivery.

What to watch

• Process of resolving Middle East conflict and actual timing of impact on supply chain normalization.
• Sustainability of Chinese chemical export data and its impact on European market prices.
• Permanent proportion of downstream customer reformulation and changes in specialty chemical demand structure.
• Whether local European procurement ratio continues to decline and if more European factories announce shutdowns.
• BASF Zhanjiang base commissioning progress and margin performance.
• Post-Novolesis merger integration progress and realization of synergies.